Literature DB >> 18604279

Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy.

T Germans1, A A M Wilde, C J A van Echteld, O Kamp, Y M Pinto, A C van Rossum.   

Abstract

Entities:  

Year:  2007        PMID： 18604279      PMCID： PMC2442895          DOI： 10.1007/bf03085974

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  13 in total

1.  Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.

Authors:  Sherif F Nagueh; Judy McFalls; Denise Meyer; Rita Hill; William A Zoghbi; James W Tam; Miguel A Quiñones; Robert Roberts; A J Marian
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

2.  Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.

Authors:  Tjeerd Germans; Arthur A M Wilde; Pieter A Dijkmans; Wenxia Chai; Otto Kamp; Yigal M Pinto; Albert C van Rossum
Journal:  J Am Coll Cardiol       Date:  2006-11-28       Impact factor: 24.094

3.  Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.

Authors:  Pascale Richard; Philippe Charron; Lucie Carrier; Céline Ledeuil; Theary Cheav; Claire Pichereau; Abdelaziz Benaiche; Richard Isnard; Olivier Dubourg; Marc Burban; Jean-Pierre Gueffet; Alain Millaire; Michel Desnos; Ketty Schwartz; Bernard Hainque; Michel Komajda
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

4.  Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.

Authors:  W J McKenna; P Spirito; M Desnos; O Dubourg; M Komajda
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

5.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

6.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Authors:  B J Maron; J M Gardin; J M Flack; S S Gidding; T T Kurosaki; D E Bild
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

7.  Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice.

Authors:  Lucie Carrier; Ralph Knöll; Nicolas Vignier; Dagmar I Keller; Pedro Bausero; Bernard Prudhon; Richard Isnard; Marie-Lory Ambroisine; Marc Fiszman; John Ross; Ketty Schwartz; Kenneth R Chien
Journal:  Cardiovasc Res       Date:  2004-08-01       Impact factor: 10.787

8.  The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands.

Authors:  Marielle Alders; Roselie Jongbloed; Wout Deelen; Arthur van den Wijngaard; Pieter Doevendans; Folkert Ten Cate; Vera Regitz-Zagrosek; Hans Peter Vosberg; Irene van Langen; Arthur Wilde; Dennis Dooijes; Marcel Mannens
Journal:  Eur Heart J       Date:  2003-10       Impact factor: 29.983

9.  Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.

Authors:  Roselie J Jongbloed; Carlo L Marcelis; Pieter A Doevendans; Judith M Schmeitz-Mulkens; Willem G Van Dockum; Joep P Geraedts; Hubert J Smeets
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

10.  A mouse model of familial hypertrophic cardiomyopathy.

Authors:  A A Geisterfer-Lowrance; M Christe; D A Conner; J S Ingwall; F J Schoen; C E Seidman; J G Seidman
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728
View more
  5 in total

1.  Evaluation of hypertrophic cardiomyopathy: new horizons for CMR?

Authors:  E E van der Wall; H M Siebelink; J J Bax
Journal:  Neth Heart J       Date:  2010-03       Impact factor: 2.380

2.  The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy.

Authors:  T Germans; R Nijveldt; W P Brouwer; J G J Groothuis; A M Beek; M J W Götte; A C van Rossum
Journal:  Neth Heart J       Date:  2010-03       Impact factor: 2.380

3.  Cardiac magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Milind Y Desai; Ashwat Dhillon; Andrew C Y To
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

4.  Left ventricular mass assessment by CMR; how to define the optimal index.

Authors:  E E van der Wall; H M Siebelink; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-06       Impact factor: 2.357

5.  Speckle tracking: distinction of physiologic from pathologic LVH?

Authors:  E E van der Wall; V Delgado; E R Holman; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-24       Impact factor: 2.357
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.